Takafumi Okabe

Izumi, 5940073, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Public assistance and survival equality in patients with EGFR mutation-positive lung cancer.

Public assistance and survival equality in patients with EGFR mutation-positive lung cancer.

Journal: Japanese journal of clinical oncology

Published: September 10, 2024

Impact of First-Line Osimertinib and Other EGFR-Tyrosine Kinase Inhibitors on Overall Survival in Untreated Advanced EGFR-Mutated Non-small Cell Lung Cancer in Japan: Updated Data from TREAD Project 01.

Impact of First-Line Osimertinib and Other EGFR-Tyrosine Kinase Inhibitors on Overall Survival in Untreated Advanced EGFR-Mutated Non-small Cell Lung Cancer in Japan: Updated Data from TREAD Project 01.

Journal: Targeted oncology

Published: August 23, 2024

Association of tumour burden with the efficacy of programmed cell death-1/programmed cell death ligand-1 inhibitors for treatment-naïve advanced non-small-cell lung cancer.

Association of tumour burden with the efficacy of programmed cell death-1/programmed cell death ligand-1 inhibitors for treatment-naïve advanced non-small-cell lung cancer.

Journal: European journal of cancer (Oxford, England : 1990)

Published: September 03, 2021

Production of functional eggs and sperm from in vitro-expanded type A spermatogonia in rainbow trout.

Production of functional eggs and sperm from in vitro-expanded type A spermatogonia in rainbow trout.

Journal: Communications biology

Published: November 25, 2019

Porous diaphragm syndrome with recurrent thymoma.

Porous diaphragm syndrome with recurrent thymoma.

Journal: Respirology case reports

Published: August 06, 2018

B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity.

B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: September 29, 2017

Phase I trial of 5-FU, docetaxel, and nedaplatin (UDON) combination therapy for recurrent or metastatic esophageal cancer.

Phase I trial of 5-FU, docetaxel, and nedaplatin (UDON) combination therapy for recurrent or metastatic esophageal cancer.

Journal: Cancer chemotherapy and pharmacology

Published: March 24, 2015

Tyrosine phosphoproteomics identifies both codrivers and cotargeting strategies for T790M-related EGFR-TKI resistance in non-small cell lung cancer.

Tyrosine phosphoproteomics identifies both codrivers and cotargeting strategies for T790M-related EGFR-TKI resistance in non-small cell lung cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 13, 2014

A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC).

A phase 1 study of linifanib in combination with carboplatin/paclitaxel as first-line treatment of Japanese patients with advanced or metastatic non-small cell lung cancer (NSCLC).

Journal: Cancer chemotherapy and pharmacology

Published: March 31, 2014

Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerization.

Cetuximab response of lung cancer-derived EGF receptor mutants is associated with asymmetric dimerization.

Journal: Cancer research

Published: September 26, 2013

Activation of HER family signaling as a mechanism of acquired resistance to ALK inhibitors in EML4-ALK-positive non-small cell lung cancer.

Activation of HER family signaling as a mechanism of acquired resistance to ALK inhibitors in EML4-ALK-positive non-small cell lung cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 31, 2012

Phase I trial of OTS11101, an anti-angiogenic vaccine targeting vascular endothelial growth factor receptor 1 in solid tumor.

Phase I trial of OTS11101, an anti-angiogenic vaccine targeting vascular endothelial growth factor receptor 1 in solid tumor.

Journal: Cancer science

Published: June 24, 2012

Showing 1-12 of 13

Last Updated: 09/26/2026